Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease ; volume:14 ; number:1 ; day:12 ; month:4 ; year:2023 ; pages:1-19 ; date:12.2023
Stem cell research & therapy ; 14, Heft 1 (12.4.2023), 1-19, 12.2023
- Urheber
-
Zhuo, Yi
Li, Xuan
He, Zhengwen
Lu, Ming
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-023-03280-0
- URN
-
urn:nbn:de:101:1-2023082521093870928857
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhuo, Yi
- Li, Xuan
- He, Zhengwen
- Lu, Ming
- SpringerLink (Online service)
Ähnliche Objekte (12)
Purinergic Signalling in Parkinson’s Disease: A Multi-target System to Combat Neurodegeneration
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease
Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies
Molecular pathways to Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease
Genetic Architecture of Parkinson’s Disease
The heterogeneity of Parkinson’s disease
Purinergic Signalling in Parkinson’s Disease: A Multi-target System to Combat Neurodegeneration
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease
Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies
Molecular pathways to Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease
Genetic Architecture of Parkinson’s Disease
The heterogeneity of Parkinson’s disease
Purinergic Signalling in Parkinson’s Disease: A Multi-target System to Combat Neurodegeneration
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease
Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies
Molecular pathways to Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease
Genetic Architecture of Parkinson’s Disease